Financial reports
10-K
2023 FY
Annual report
21 Mar 24
10-Q
2023 Q3
Quarterly report
13 Nov 23
ARS
2022 FY
Annual report to shareholders
20 Oct 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
10-Q
2023 Q1
Quarterly report
25 May 23
NT 10-Q
Notice of late quarterly filing
15 May 23
10-K
2022 FY
Annual report
15 Mar 23
10-Q
2022 Q3
Quarterly report
14 Nov 22
Current reports
8-K
Other Events
29 Apr 24
8-K
Other Events
23 Apr 24
8-K
Shuttle Pharma Provides Fourth Quarter 2023 Corporate Update
22 Mar 24
8-K
Shuttle Pharmaceuticals to Present at About Shuttle Pharmaceuticals
5 Mar 24
8-K
Shuttle Pharma Announces Its Intent to Pursue a Rights Offering
13 Feb 24
8-K
Entry into a Material Definitive Agreement
5 Feb 24
8-K
Shuttle Pharmaceuticals Receives FDA approval to Proceed with Phase II Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma
8 Jan 24
8-K
Submission of Matters to a Vote of Security Holders
19 Dec 23
8-K
Shuttle Pharmaceuticals Submits IND Application to the U.S. FDA for Ropidoxuridine Phase II Clinical Trial for Patients with Glioblastoma
11 Dec 23
8-K
Other Events
30 Nov 23
Registration and prospectus
S-1
IPO registration
5 Apr 24
424B3
Prospectus supplement
22 Mar 24
424B3
Prospectus supplement
24 Aug 23
424B3
Prospectus supplement
1 Feb 23
S-1/A
IPO registration (amended)
30 Jan 23
S-1
IPO registration
25 Jan 23
D
$4.00 mm in securities to be acquired, sold $4.00 mm, 1 investor
20 Jan 23
S-8
Registration of securities for employees
12 Dec 22
DRS
Draft registration statement
29 Sep 22
424B4
Prospectus supplement with pricing info
31 Aug 22
Other
EFFECT
Notice of effectiveness
2 Feb 23
CORRESP
Correspondence with SEC
30 Jan 23
CORRESP
Correspondence with SEC
27 Jan 23
UPLOAD
Letter from SEC
27 Jan 23
CORRESP
Correspondence with SEC
25 Jan 23
UPLOAD
Letter from SEC
31 Aug 22
EFFECT
Notice of effectiveness
30 Aug 22
CERT
Certification of approval for exchange listing
29 Aug 22
CORRESP
Correspondence with SEC
25 Aug 22
CORRESP
Correspondence with SEC
23 Aug 22
Ownership
4
Chris Senanayake
14 Mar 24
4
Hoek Michael Vander
8 Mar 24
4
Milton Brown
2 Jan 24
4
Bette Jacobs
20 Dec 23
SC 13G/A
AFH Holding & Advisory, LLC
18 Oct 23
4
Anatoly Dritschilo
18 Aug 23
SC 13G
AFH Holding & Advisory, LLC
30 May 23
SC 13G
AFH Holding & Advisory, LLC
6 Mar 23
4
Milton Brown
17 Feb 23
4
Steven M Richards
9 Jan 23